// App-Quantinova.ai

QOL35 : Patient-Reported Outcome Measures in Multiple Sclerosis Clinical Trials: Critical Assessment and Insights from People Living with Multiple Sclerosis

Researchers

Presenter

  • Trishna Bharadia

Principal Investigators

  • Tanuja Chitnis

  • Piet Eelen

  • Birgit Bauer

  • Giampaolo Brichetto

  • Andrew Lloyd

  • Hollie Schmidt

  • Miriam King

  • Jenny Fitzgerald

  • Thomas Hach

  • Jo Vandercappellen

  • Jeremy Hobart

Medical Centers

  • Faculty of Medicine and Dentistry, University of Plymouth, Plymouth, United Kingdom

  • National Multiple Sclerosis Center of Melsbroek, Flanders, Belgium

  • Marlow, United Kingdom

  • Manufaktur für Antworten (UG), Abensberg, Germany

  • Accelerated Cure Project for Multiple Sclerosis, Waltham, MA

  • Associazione Italiana Sclerosi Multipla Rehabilitation Center, Genoa, Italy

  • Brigham and Women’s Hospital, Department of Dermatology, Boston, MA

  • Novartis AG, Basel, Switzerland

Locations

  • United Kingdom

  • United States

  • Belgium

  • Italy

  • Germany

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved